Stay updated with breaking news from David bunka. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
With alternative technologies available, we should be seeking antibody alternatives that avoid the unnecessary use of animals in research, urges Dr Davi. ....
Oligonucleotide affinity ligands developer Aptamer Group has developed a panel of binders to a novel Alzheimer’s disease biomarker, patented by partners at Neuro-Bio, following the demonstration of performance in specifically binding to the target biomarker and functionality in a nasal mucous matrix. Click to read more. ....